Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2023. Read More.
Open Access Percentage
85%
Total
Publications
659
Total Open
Publications
561
Total
Citations
28K
Open Access
Percentage
85%
Total
Publications
659
Total Open
Publications
561
Total
Citations
28K
Breakdown
Publisher Open
10%
Both
64%
Other Platform Open
11%
Closed
15%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 58%
284
Hybrid 31%
148
No Guarantees 11%
54
Other Platform Open
Domain 82%
408
Institution 46%
231
Other Internet 14%
69
Public 13%
67
Preprint 11%
53
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 407 |
Europe PMC | Domain | 228 |
Semantic Scholar | Public | 54 |
University College London - UCL Discovery | Institution | 37 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 35 |
lshtm.ac.uk OAI-PMH Repository | Institution | 33 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 33 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 31 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 24 |
DOI | Other Internet | 24 |